Skip to main content

Published locations for Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitis

User login

  • Reset your password
  • /content/melanoma-survival-shorter-those-given-high-dose-glucocorticoids-ipilimumab-induced
  • /edermatologynews/article/170493/immunotherapy/melanoma-survival-shorter-those-given-high-dose
  • /oncologypractice/article/170493/immunotherapy/melanoma-survival-shorter-those-given-high-dose
  • /hematology-oncology/article/170493/immunotherapy/melanoma-survival-shorter-those-given-high-dose
  • /dermatology/article/170493/immunotherapy/melanoma-survival-shorter-those-given-high-dose